Ginette 35 Tablet
Marketer
Cipla Ltd
Salt Composition
Cyproterone (2mg) + Ethinyl Estradiol (0.035mg)
Overview Ginette 35 Tablet
Cyproterone acetate and ethinylestradiol tablets (Ginette 35 equivalent) combine two hormones to manage polycystic ovary syndrome (PCOS) symptoms like unwanted hair growth, acne, and menstrual irregularities. This medication also acts as a contraceptive; therefore, avoid concurrent use of other birth control pills. It can be ingested with or without food, but consistent daily timing aids adherence. Dosage and treatment length vary depending on the condition being treated; however, always finish the prescribed course. Common side effects include nausea, abdominal discomfort, headaches, weight increase, and breast tenderness. Report any concerning or persistent side effects to your physician; management options may be available. Consult your doctor regarding any mid-cycle spotting or brownish discharge. Seek immediate medical attention for unexplained limb swelling or pain, breathlessness, chest pain, or vision disturbances. Discontinue use and contact your doctor if menstruation doesn't begin within a week of treatment completion. Inform your physician of all other medications you're using, as interactions may reduce efficacy or alter the drug's effects. Do not use this medication during pregnancy or while breastfeeding.
Primary Ingredients of Ginette 35 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Ginette 35 Tablet
Managing Polycystic Ovary Syndrome (PCOS)
Major Benefits of Ginette 35 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ginette 35 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ginette 35 Tablet:
- Nausea
- Stomach pain
- Headache
- Weight gain
- Breast pain
- Mood changes
How to use Ginette 35 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Ginette 35 Tablets can be administered with or without food, but consistency in timing is recommended.
How Ginette 35 Tablet works:
Ginette 35 is a combined oral contraceptive containing cyproterone acetate and ethinyl estradiol, effectively managing Polycystic Ovary Syndrome (PCOS) manifestations like acne, hirsutism, and menstrual irregularities. Cyproterone acetate mitigates excessive androgen production within the ovaries, lessening acne and unwanted hair. Ethinyl estradiol complements this action by further suppressing circulating androgens. This synergistic effect also normalizes the menstrual cycle in women with PCOS.
SAFETY ADVICE
AlcoholCAUTION
Using Ginette 35 Tablets with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ginette 35 during pregnancy poses a significant risk. Pregnant women should consult their physician immediately; research in animal and human studies indicates substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Using Ginette 35 tablets while breastfeeding is likely inadvisable. Preliminary evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ginette 35.
KidneyCONSULT YOUR DOCTOR
Data on Ginette 35 Tablet use in individuals with impaired kidney function is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Ginette 35 Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ginette 35 Tablet :
Should you forget a Ginette 35 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ginette 35 Tablet
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Obstetrics and Gynecology |